BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 16006966)

  • 1. Identification of tumor entities of renal cell carcinoma using interphase fluorescence in situ hybridization.
    Sanjmyatav J; Rubtsov N; Starke H; Schubert J; Hindermann W; Junker K
    J Urol; 2005 Aug; 174(2):731-5. PubMed ID: 16006966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of quantitative chromosomal abnormalities in renal cell carcinomas by interphase four-color fluorescence in situ hybridization.
    Receveur AO; Couturier J; Molinié V; Vieillefond A; Desangles F; Guillaud-Bataille M; Danglot G; Coullin P; Bernheim A
    Cancer Genet Cytogenet; 2005 Apr; 158(2):110-8. PubMed ID: 15796957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of deletions in the short arm of chromosome 3 in uncultured renal cell carcinomas by interphase cytogenetics.
    Siebert R; Jacobi C; Matthiesen P; Zühlke-Jenisch R; Potratz C; Zhang Y; Stöckle M; Klöppel G; Grote W; Schlegelberger B
    J Urol; 1998 Aug; 160(2):534-9. PubMed ID: 9679924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic usefulness of fluorescent cytogenetics in differentiating chromophobe renal cell carcinoma from renal oncocytoma: a validation study combining metaphase and interphase analyses.
    Brunelli M; Delahunt B; Gobbo S; Tardanico R; Eccher A; Bersani S; Cossu-Rocca P; Parolini C; Balzarini P; Menestrina F; Cheng L; Eble JN; Martignoni G
    Am J Clin Pathol; 2010 Jan; 133(1):116-26. PubMed ID: 20023267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinomas.
    Mosquera JM; Dal Cin P; Mertz KD; Perner S; Davis IJ; Fisher DE; Rubin MA; Hirsch MS
    Diagn Mol Pathol; 2011 Sep; 20(3):129-37. PubMed ID: 21817901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal cell carcinoma sub-typing by histopathology and fluorescence in situ hybridization on a needle-biopsy specimen.
    Barocas DA; Mathew S; DelPizzo JJ; Vaughan ED; Sosa RE; Fine RG; Akhtar M; Scherr DS
    BJU Int; 2007 Feb; 99(2):290-5. PubMed ID: 17092279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
    Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
    Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FISH scoring on paraffin sections versus single-cell suspension for chromophobe renal carcinoma and renal oncocytoma.
    Brunelli M; Segala D; Delahunt B; Parolini C; Bersani S; Cheng L; Eble JN; Chilosi M; Gobbo S; Martignoni G
    Anticancer Res; 2011 Oct; 31(10):3137-42. PubMed ID: 21965719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
    Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
    Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD70: a new tumor specific biomarker for renal cell carcinoma.
    Junker K; Hindermann W; von Eggeling F; Diegmann J; Haessler K; Schubert J
    J Urol; 2005 Jun; 173(6):2150-3. PubMed ID: 15879877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosome 1 analysis in chromophobe renal cell carcinomas with tissue microarray (TMA)-facilitated fluorescence in situ hybridization (FISH) demonstrates loss of 1p/1 which is also present in renal oncocytomas.
    Meyer PN; Cao Y; Jacobson K; Krausz T; Flanigan RC; Picken MM
    Diagn Mol Pathol; 2008 Sep; 17(3):141-4. PubMed ID: 18382368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of oncocytic papillary renal cell carcinoma.
    Okada A; Sasaki S; Fujiyoshi Y; Niimi K; Kurokawa S; Umemoto Y; Kohri K
    Int J Urol; 2009 Sep; 16(9):765-7. PubMed ID: 19769658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influence of interphase nuclei preparation techniques on fluorescence in situ hybridization results in solid tumors].
    Han YL; Xu X; Cai Y; Wang MR
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Jun; 24(3):331-3. PubMed ID: 17557250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid prenatal diagnosis of Down syndrome using quantitative fluorescence in situ hybridization on interphase nuclei.
    Truong K; Gibaud A; Dupont JM; Guilly MN; Soussaline F; Dutrillaux B; Malfoy B
    Prenat Diagn; 2003 Feb; 23(2):146-51. PubMed ID: 12575023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interphase fluorescence in situ hybridization analysis: a study using centromeric probes 7, 8, and 12.
    Zhao L; Khan Z; Hayes KJ; Glassman AB
    Ann Clin Lab Sci; 1998; 28(1):51-6. PubMed ID: 9512785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of renal cell carcinoma by CGH, multicolor-FISH and conventional cytogenic banding analysis.
    Sanjmyatav J; Schubert J; Junker K
    Oncol Rep; 2005 Nov; 14(5):1183-7. PubMed ID: 16211283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescence in situ hybridization as an adjunct tool in the diagnosis of primary and metastatic renal cell carcinoma in fine needle aspiration specimens.
    Kos Z; Williams PA; Belanger EC; Mai KT
    Diagn Cytopathol; 2014 Dec; 42(12):1013-23. PubMed ID: 24692327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity.
    Gobbo S; Eble JN; Grignon DJ; Martignoni G; MacLennan GT; Shah RB; Zhang S; Brunelli M; Cheng L
    Am J Surg Pathol; 2008 Aug; 32(8):1239-45. PubMed ID: 18594469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescence in situ hybridization method in isolated single nuclei extracted from paraffin-embedded hepatocellular carcinoma tissues.
    Tantiwetrueangdet A; Panvichian R; Sornmayura P; Pinpradap K; Leelaudomlipi S
    J Med Assoc Thai; 2007 Feb; 90(2):363-8. PubMed ID: 17375644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interphase fluorescence in situ hybridization is more sensitive than BIOMED-2 polymerase chain reaction protocol in detecting IGH-BCL2 rearrangement in both fixed and frozen lymph node with follicular lymphoma.
    Belaud-Rotureau MA; Parrens M; Carrere N; Turmo M; Ferrer J; de Mascarel A; Dubus P; Merlio JP
    Hum Pathol; 2007 Feb; 38(2):365-72. PubMed ID: 17134735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.